Treatment of autistic schizophrenic children with LSD-25 and UML-491.
D001321:Autistic Disorder; D002648:Child; D006801:Humans; D007223:Infant; D008238:Lysergic Acid Diethylamide / Q000031:analogs & derivatives / Q000628:therapy*; D008784:Methysergide; D012559:Schizophrenia
D008238:Lysergic Acid Diethylamide; D008784:Methysergide
LYSERGIC ACID DIETHYLAMIDE/related compounds; LYSERGIC ACID DIETHYLAMIDE/therapy; SCHIZOPHRENIA/in infancy and childhood